CD164 and intrahepatic cholangiocarcinoma: It is noteworthy that a significant proportion of cells, specifically 63%, exhibited positive expression of CD164, a finding that was consistent with the results obtained from the previous ICC analysis, as depicted in Figure 2C and Figure 3A. Four additional female SSC populations were examined using the marker panel previously reported.